By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Rafael Pharmaceuticals (Formerly known as Cornerstone Pharmaceuticals, Inc.) 

1 Duncan Drive

Cranbury  New Jersey  08512  U.S.A.
Phone: 609-409-7050 Fax: 609-409-6035



Company News
Rafael Pharma (Formerly known as Cornerstone Pharma) To Present Late Breaking Data At The 2017 European Society For Medical Oncology (ESMO) Annual Meeting 9/8/2017 7:55:08 AM
Cornerstone Pharmaceuticals, Inc. Announces Corporate Name Change to Rafael Pharmaceuticals 6/5/2017 10:48:10 AM
The Lancet Oncology Publishes Phase I Data Demonstrating The Safety, Tolerability, And Preliminary Efficacy Of Cornerstone Pharmaceuticals, Inc.’ CPI-613 In Combination With Modified FOLFIRINOX In Patients With Metastatic Pancreatic Cancer 5/9/2017 10:51:21 AM
FDA Provides Cornerstone Pharmaceuticals, Inc. Approval To Initiate Pivotal Study For CPI-613, Its Metabolism-Directed Anticancer Compound 3/23/2017 8:34:23 AM
Cornerstone Pharmaceuticals, Inc. Announces The Addition Of World-Renowned Experts To Scientific And Medical Advisory Boards 2/8/2017 10:22:40 AM
Cornerstone Pharmaceuticals, Inc. Release: Pharma Announces Additions To Its Board Of Directors: Jean-Pierre Sommadossi, Ph.D., Richard Axel, M.D., Chi Van Dang, M.D., Ph.D., And Richard Scheller, Ph.D. 1/11/2017 6:44:33 AM
Cornerstone Pharmaceuticals, Inc. Presents Phase I Data On CPI-613 In Acute Myeloid Leukemia (AML) And T-Cell Non-Hodgkin's Lymphoma (T-Cell NHL) At American Society of Hematology 2016 12/6/2016 6:48:16 AM
Cornerstone Pharmaceuticals, Inc. Appoints Brian Mullaney, M.D., Ph.D., As Chief Medical Officer 11/29/2016 7:58:12 AM
IDT Corporation Announces Investment In Cornerstone Pharmaceuticals, Inc. 11/10/2016 3:37:53 PM
Cornerstone Pharmaceuticals, Inc. To Present At The LEERINK Partners 5th Annual Global Healthcare Conference On Wednesday, February 10, 2016 2/9/2016 8:02:46 AM